The objective of the study was to investigate the efficacy and safety of hexaminolevulinate ( HAL ) photodynamic therapy ( PDT ) , a novel therapy for women with cervical intraepithelial neoplasia ( CIN ) 1/2 , to define the appropriate population and endpoints for a phase 3 program .